Premenopausal women with early breast cancer treated with estradiol suppression have severely deteriorated bone microstructure-Reference-Cited by-同舟云学术

Premenopausal women with early breast cancer treated with estradiol suppression have severely deteriorated bone microstructure

Published:2017-10 Issue: Volume:103 Page:131-135
ISSN:8756-3282
Container-title:Bone
language:en
Short-container-title:Bone

Author:

Ramchand Sabashini K.,Seeman Ego,Wang Xiao-Fang,Ghasem-Zadeh Ali,Francis Prudence A.,Ponnusamy Evangeline J.,Bardin Michele S.,Bui Minh,Zebaze Roger,Zajac Jeffrey D.,Grossmann Mathis

Publisher

Elsevier BV

Subject

Histology,Physiology,Endocrinology, Diabetes and Metabolism

Reference27 articles.

1. Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials;Dowsett;Lancet,2015

2. Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial;Gnant;Lancet,2015

3. Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results;Coleman;Ann. Oncol.,2013

4. Adjuvant ovarian suppression in premenopausal breast cancer;Francis;N. Engl. J. Med.,2015

5. Adjuvant exemestane with ovarian suppression in premenopausal breast cancer;Pagani;N. Engl. J. Med.,2014

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Denosumab Prevents Bone Loss and Microarchitectural Deterioration in Premenopausal Women With Breast Cancer Receiving Estradiol Suppression Therapy: A Randomized Controlled Trial;Journal of Clinical Oncology;2024-07-02

2. Systemische Therapie von prämenopausalen Patientinnen mit hormonrezeptorpositivem, HER2-negativem Brustkrebs in den Frühstadien – Kontroversen und Standards in der Krankenversorgung;Senologie - Zeitschrift für Mammadiagnostik und -therapie;2024-03

3. Systemic Therapy of Premenopausal Patients with Early Stage Hormone Receptor-Positive, HER2-Negative Breast Cancer – Controversies and Standards in Healthcare;Geburtshilfe und Frauenheilkunde;2023-05-23

4. Role of Ovarian Suppression in Early Premenopausal Breast Cancer;Hematology/Oncology Clinics of North America;2023-02

5. Review of bone health in women with estrogen receptor–positive breast cancer receiving endocrine therapy;Women's Health;2023-01